Tate Leah 4

4 · BELDEN INC. · Filed May 14, 2025

Form 4

Period: 2025-05-13

EVP - Chief Peop/Strat Officer

Transactions

Exercise/Conversion
Common Stock
2025-05-13$85.77/sh+1,667$142,979→ 31,837 total
Disposition to Issuer
Common Stock
2025-05-13$113.85/sh−1,436$163,489→ 30,401 total
Sale
Common Stock
2025-05-14$113.64/sh−231$26,251→ 30,170 total
Exercise/Conversion
Stock Appreciation Rights
2025-05-13−1,667→ 1,666 total
Exercise: $85.77Exp: 2033-03-07→ Common Stock (1,667 underlying)

Holdings

Footnotes (5)

[F1]The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.
[F2]This represents the difference between the number of SARs exercised (1,667) and the number of shares issued as a result of the exercise (231). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($113.85) and the exercise price ($85.77). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
[F3]Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
[F4]The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.
[F5]The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.

Documents

2 files